TrialBone marrow transplantation2015

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.

M Hengeveld et al.PubMed ↗Publisher ↗

No numbers read from the abstract.